Invasive mold infections in allogeneic bone marrow transplant recipients

Clinical Infectious Diseases

Volumn 32, Issue 9, 2001, Pages 1319-1324

  Baddley, John W ^a   Stroud, Thomas P ^b   Salzman, Donna ^b   Pappas, Peter G ^a  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; CEFTAZIDIME; CIPROFLOXACIN; CYCLOSPORIN; GLUCOCORTICOID; METHOTREXATE; METHYLPREDNISOLONE; NYSTATIN; PIPERACILLIN; PYRROLE DERIVATIVE; THYMOCYTE ANTIBODY; TOBRAMYCIN; VANCOMYCIN;

ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; ASPERGILLUS FUMIGATUS; BIOPSY; CONTROLLED STUDY; FEMALE; FOLLOW UP; FUNGUS CULTURE; GRAFT VERSUS HOST REACTION; HUMAN; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MORTALITY; MOULD; MYCOSIS; PRIORITY JOURNAL; RISK FACTOR; THORAX RADIOGRAPHY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ASPERGILLOSIS; ASPERGILLUS; ASPERGILLUS FUMIGATUS; BONE MARROW TRANSPLANTATION; FEMALE; HUMANS; MADUROMYCOSIS; MALE; MIDDLE AGED; MUCOR; MUCORMYCOSIS; OPPORTUNISTIC INFECTIONS; RETROSPECTIVE STUDIES; RISK FACTORS; SCEDOSPORIUM; SURVIVAL RATE; TRANSPLANTATION, HOMOLOGOUS;

EID: 0035341392     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/319985     Document Type: Article

References (21)

1. Fungal infections in bone marrow transplant patients
2. Nosocomial pneumonia in patients having bone marrow transplant: Attributable mortality, and risk factors
3. Nosocomial aspergillosis: Environmental microbiology, hospital epidemiology, diagnosis, and treatment
4. Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients
5. Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation
6. Prediction of systemic fungal infection in allogeneic marrow recipients: Impact of amphotericin prophylaxis in high-risk patients
7. Non-Candida fungal infection after bone marrow transplantation: Risk factors and outcome
8. Antifungal and surgical treatment of invasive aspergillosis: Review of 2121 published cases
9. Hematopoietic stem cell transplantation transplantation
10. Analysis of definitions used in clinical research on invasive fungal infections (IFI): Consensus proposal for new, standardized definitions
11. Pulmonary aspergillosis during hospital renovation
12. Nosocomial aspergillosis: A retrospective review of airborne disease secondary to road construction and contaminated air conditioners
13. Increased recovery of Aspergillus flavus from respiratory specimens during hospital construction
14. Survival and prognostic factors of invasive aspergillosis after allogeneic bone marrow transplantation
15. Aspergillus infections in bone marrow transplant recipients
16. Epidemiology and diagnosis of invasive pulmonary aspergillosis in bone marrow transplant patients: Results of a 5-year retrospective study
17. In vitro amphotericin B resistance in clinical isolates of Aspergillus terreus, with a head-to-head comparison to voriconazole
18. Comparison of in vitro activity of liposomal nystatin against Aspergillus species with those of nystatin, amphotericin B (AB) deoxycholate, AB colloidal dispersion, liposomal AB, AB lipid complex, and itraconazole
19. Risk of infectious complications in patients taking corticosteroids
20. Variables predicting bacterial and fungal infections after allogeneic marrow engraftment
21. Risk factors for fungal infection in patients with malignant hematologic disorders: Implications for empirical therapy and prophylaxis